[1]
Kamrun Naher and Akterun Nahar 2026. Intrauterine Misoprostol Versus Intravenous Oxytocin for the Prevention of Primary Postpartum Hemorrhage During Cesarean Section: A One-Year Randomized Controlled Trial. Eastern Medical College Journal . 10, 2 (Jan. 2026), 111–115. DOI:https://doi.org/10.3329/emcj.v10i2.85706.